Anzeige
Erschienen in:
15.10.2016 | Topic Paper
National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis
Erschienen in: World Journal of Urology | Ausgabe 6/2017
Einloggen, um Zugang zu erhaltenAbstract
Background
Macroeconomic indicators are likely associated with prostate cancer (PCa) incidence and mortality globally, but have rarely been assessed.
Methods
Data on PCa incidence in 2003–2007 for 49 countries with either nationwide cancer registry or at least two regional registries were obtained from Cancer Incidence in Five Continents Vol X and national PCa mortality for 2012 from GLOBOCAN 2012. We compared PCa incidence and mortality rates with various population-level indicators of health, economy and development in 2000. Poisson and linear regression methods were used to quantify the associations.
Results
PCa incidence varied more than 15-fold, being highest in high-income countries. PCa mortality exhibited less variation, with higher rates in many low- and middle-income countries. Healthcare expenditure (rate ratio, RR 1.46, 95 % CI 1.45–1.47) and population growth (RR 1.15, 95 % CI 1.14–1.16), as well as computer and mobile phone density, were associated with a higher PCa incidence, while gross domestic product, GDP (RR 0.94, 95 % CI 0.93–0.95) and overall mortality (RR 0.72, 95 % CI 0.71–0.73) were associated with a low incidence. GDP (RR 0.55, 95 % CI 0.46–0.66) was also associated with a low PCa mortality, while life expectancy (RR 3.93, 95 % CI 3.22–4.79) and healthcare expenditure (RR 1.20, 95 % CI 1.09–1.32) were associated with an elevated mortality.
Conclusions
Our results show that healthcare expenditure and, thus, the availability of medical resources are an important contributor to the patterns of international variation in PCa incidence. This suggests that there is an iatrogenic component in the current global epidemic of PCa. On the other hand, higher healthcare expenditure is associated with lower PCa death rates.